Literature DB >> 1198126

Diagnosis and classification of the polycythemias.

N I Berlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1198126

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  64 in total

1.  The effect of haematocrit on transthoracic electrical impedance and on the calculation of cardiac output by an impedance cardiograph.

Authors:  A Thomas; A Vohra; B Pollard
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcome.

Authors:  Mohamad Cherry; Marylou Cardenas-Turanzas; Hannah Pham; Hagop Kantarjian; Jorge Cortes; Sherry Pierce; Lingsha Zhou; Srdan Verstovsek
Journal:  Leuk Res       Date:  2013-08-14       Impact factor: 3.156

3.  Objective, planimetry-based assessment of megakaryocyte histological pictures in Philadelphia-chromosome-negative chronic myeloproliferative disorders: a perspective for a valuable adjunct diagnostic tool.

Authors:  Zbigniew Rudzki; Rafał Kawa; Krzysztof Okoñ; Ewa Szczygieł; Jerzy Stachura
Journal:  Virchows Arch       Date:  2005-10-12       Impact factor: 4.064

4.  The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states.

Authors:  A W Cashell; D H Buss
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

5.  Ph-negative and bcr-negative atypical chronic myelogenous leukemia: biological features and clinical outcome.

Authors:  E Montefusco; G Alimena; F Lo Coco; M R De Cuia; Y Z Wang; M A Aloe Spiriti; F Mancini; M Cedrone; M Mancini; F Mandelli
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

6.  Erythroid colony growth from peripheral blood and bone marrow in polycythaemia.

Authors:  G S Masters; P Baines; A Jacobs
Journal:  J Clin Pathol       Date:  1990-11       Impact factor: 3.411

7.  Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study.

Authors:  François Girodon; Gilles Bonicelli; Céline Schaeffer; Morgane Mounier; Serge Carillo; Ingrid Lafon; Paule Marie Carli; Inès Janoray; Emmanuelle Ferrant; Marc Maynadié
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

8.  The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical study.

Authors:  Zbigniew Rudzki; Tomasz Sacha; Anastazja Stój; Sylwia Czekalska; Małgorzata Wójcik; Aleksander B Skotnicki; Barbara Grabowska; Andrzej Zduńczyk; Krzysztof Okoń; Jerzy Stachura
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

9.  Activated phenotype in neutrophils and monocytes from patients with primary proliferative polycythaemia.

Authors:  N B Westwood; E R Copson; L A Page; A R Mire-Sluis; K A Brown; T C Pearson
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

10.  Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.

Authors:  Ola Landgren; Lynn R Goldin; Sigurdur Y Kristinsson; Elin A Helgadottir; Jan Samuelsson; Magnus Björkholm
Journal:  Blood       Date:  2008-05-01       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.